Kimia Biosciences gets permission to manufacture, market ‘Fimasartan Potassium Trihydrate API’

23 Jul 2020 Evaluate
Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical Ingredient ‘Fimasartan Potassium Trihydrate API’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

31.93 -0.58 (-1.78%)
08-Jan-2026 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1769.85
Dr. Reddys Lab 1222.00
Cipla 1463.80
Zydus Lifesciences 925.00
Lupin 2200.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×